Oncotarget

Oct 14, 2026 — BUFFALO, NY – October 14, 2026 – A new #research paper was #published in Volume 17 of #Oncotarget on October 12, 2026, titled “Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived compounds.” The study examined...

No transcript available.

Oct 06, 2026 — Cancer cells often survive by disrupting the molecular pathways that normally eliminate damaged or abnormal cells. One of these pathways is apoptosis, a tightly controlled form of programmed cell death. New research suggests that an apoptosis-related...

No transcript available.

Sep 28, 2026 — BUFFALO, NY – September 28, 2026 – A new #editorial was #published in Volume 17 of Oncotarget on September 23, 2026, titled “Gut feeling: Microbes at the heart of cancer therapy.” The article examines how the human microbiome may influence cancer...

No transcript available.

Sep 23, 2026 — Cancer cells do not grow in isolation. Their ability to survive and form tumors depends partly on how they interact with immune cells in the surrounding tumor microenvironment. Melanoma is particularly responsive to immune-based mechanisms, making it...

No transcript available.

Sep 17, 2026 — BUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?” The paper was authored by Raphael Lataster, an independent...

No transcript available.